Clinical Trial Update: Fecal Microbiota Transplant and Pembrolizumab for Men With Metastatic Castration Resistant Prostate Cancer. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial exploring fecal microbiota transplant in combination with pembrolizumab for metastatic castration-resistant prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• Fecal microbiota transplant (fecal microbiota transplant)
• Pembrolizumab (pembrolizumab)

Snippet

Sponsor: Julie Graff, MD | Conditions: Prostate Cancer, Prostate Cancer Metastatic | Phase 2 | Status: UNKNOWN